Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metabolic Alcohol-associated Liver Disease”

15 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 15 of 15 results

Not applicableStudy completedNCT06924281
What this trial is testing

Team Science (The Liver Health Study)

Who this might be right for
Steatotic Liver Disease of Mixed Origin (MetALD)
Brown University 14
Large-scale testing (Phase 3)Looking for participantsNCT06461208
What this trial is testing

A PROspective Faecal MIcrobiota tranSplantation Trial to Improve outcomEs in Patients With Cirrhosis

Who this might be right for
Liver Cirrhosis
King's College London 300
Not applicableUnknownNCT06403332
What this trial is testing

Study of the Drivers of Late Diagnosis of Alcohol Related Diseases, Alone or in Combination With Metabolic Dysfunconal Associated Fatty Liver Disease, Implementation and Evaluation of Itnerventions to Reduce Its Burden.

Who this might be right for
Alcohol-related Liver DiseaseAlcohol Use DisorderMetabolic and Alcohol Related/Associated Liver Disease+1 more
Hospital Universitari Vall d'Hebron Research Institute 350
Not applicableLooking for participantsNCT07068191
What this trial is testing

Gepaktiv vs UDCA and Ademetionine in MAFLD With Hepatomegaly

Who this might be right for
Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD)HepatomegalyNonalcoholic Fatty Liver (NAFL)+5 more
Phenomen Pharma 90
Not applicableLooking for participantsNCT05623150
What this trial is testing

CHronic Hepatopathies Associated With ALcohol Consumption aNd metAbolic Syndrome

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseNon-Alcoholic SteatohepatitisAlcohol-related Liver Disease+2 more
Institut National de la Santé Et de la Recherche Médicale, France 710
Not applicableEnrolling By InvitationNCT06514300
What this trial is testing

Investigating Myosteatosis in Steatotic Liver Diseases

Who this might be right for
Alcohol-related Liver DiseaseMetabolic Dysfunction Associated Steatotic Liver DiseaseSteatotic Liver Disease of Mixed Origin (MetALD)+5 more
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 100
Testing effectiveness (Phase 2)Looking for participantsNCT07046819
What this trial is testing

Tirzepatide in MetALD

Who this might be right for
Metabolic Alcohol-associated Liver DiseaseAlcohol Use Disorder
National Institute on Alcohol Abuse and Alcoholism (NIAAA) 120
Not applicableNot Yet RecruitingNCT06797596
What this trial is testing

Clinical Correlation Evaluation of the LIVERFASt Test for Diagnosing Important Liver Lesions of Fibrosis and Steatosis Against Magnetic Resonance Elastography (MRE) for Liver Fibrosis and MR-based Assessment of Steatosis, in Adult US Population.

Who this might be right for
Liver Fibrosis Due to NASHMASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseAlcohol Liver Disease
Fibronostics USA, Inc 100
Not applicableNot Yet RecruitingNCT07087041
What this trial is testing

Predict Recompensation in Patients With Decompensated Cirrhosis Using Spleen Stiffness and Simple Blood Tests

Who this might be right for
Decompensated CirrhosisHepatitis B Virus (HBV) InfectionMetabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)+3 more
Beijing Friendship Hospital 735
Not applicableEnrolling By InvitationNCT07199491
What this trial is testing

Testing a Multilevel, Culturally Appropriate Lifestyle Intervention For Hispanic Patients With Metabolic Dysfunction-associated Steatotic Liver Disease

Who this might be right for
Metabolic-dysfunction Associated Liver Disease (MASLD)
The University of Texas Health Science Center, Houston 64
Early research (Phase 1)Looking for participantsNCT07358546
What this trial is testing

Efimosfermin Alfa in Adults With Hepatic Impairment

Who this might be right for
Non-alcoholic Fatty Liver Disease
GlaxoSmithKline 32
Not applicableNot Yet RecruitingNCT06907563
What this trial is testing

Long-term Follow-up to Determine Outcome in Liver Disease (LOVE Study)

Who this might be right for
Steatotic Liver DiseaseMASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)Steatotic Liver Disease of Mixed Origin (MetALD)+1 more
Universität des Saarlandes 30,000
Not applicableLooking for participantsNCT01793168
What this trial is testing

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Who this might be right for
Rare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+340 more
Sanford Health 20,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT07024212
What this trial is testing

Phase II Study Evaluating the Efficacy and Safety of DR10624 Injection in MASLD and MetALD Subjects

Who this might be right for
MASLD
Zhejiang Doer Biologics Co., Ltd. 110
Not applicableLooking for participantsNCT07450144
What this trial is testing

A Large Language Model-based Chatbot for Alcohol Reduction in Patients With Metabolic Alcohol-Related Liver Disease

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseMetabolic Alcohol-Related Liver Disease
The University of Hong Kong 50